⚠ FOR RESEARCH USE ONLY
CJC+Ipamorelin

CHEMICAL PROPERTIES

CAS NUMBERN/A — Combination
MOLECULAR WEIGHTN/A — Combination
MOLECULAR FORMULACJC-1295 (No DAC) + Ipamorelin

PHYSICAL PROPERTIES

APPEARANCEWhite lyophilized powder in sealed borosilicate glass vial.
SEQUENCECJC-1295 No DAC + Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH₂)

CJC+Ipamorelin

CJC-Ipamorelin is a lyophilized research blend containing CJC-1295 (no DAC) and Ipamorelin peptide reference standards, ≥99.362% purity by HPLC. For in-vitro analytical reference use. Not for use in any living organism.

1
Free shipping on orders over $150
2-day delivery
LOT NUMBERLMO-0626-CI-010
REPORT NO.KVR-2026-AD723E
HPLC PURITY99.362%

Third-Party Verified

HPLC PurityIndependent lab
IdentitySequence confirmed
ContentExact mg verified
✓
VERIFIED
⚠

RESEARCH USE ONLY

This compound is sold strictly for in vitro research and laboratory use. Not for human or animal consumption. Not a drug, food, or supplement. By purchasing you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws. Must be 21 or older.

RESEARCH

Ipamorelin, the First Selective Growth Hormone Secretagogue
Raun K, Hansen BS, Johansen NL, et al. · European Journal of Endocrinology · 1998
Establishes Ipamorelin as a selective GHS-R1a agonist without cortisol or prolactin effects, providing the complementary GH pulse axis for the CJC/Ipamorelin dual-mechanism blend.
PMID 9849822
Synergistic Effects of GHRH and GHRP on Growth Hormone Secretion In Vivo
Bowers CY, Sartor AO, Reynolds GA, Badger TM. · Endocrinology · 1991
Early in vivo study demonstrating that co-administration of GHRH and a GHRP produces a synergistic GH response significantly greater than either compound alone — the mechanistic basis for combined secretagogue research.
PMID 1846653

LAB RESULTS

LOT LMO-0626-CI-010 · CURRENT

Certificate of Analysis

PURITY
99.362%
CAS
N/A — Combination
MW
N/A — Combination
APPEARANCE
White lyophilized powder in sealed borosilicate glass vial.
VERIFIED
↓ DOWNLOAD PDF

Third-Party Report

TESTING LABKovera Labs
TEST DATE08/16/2026
METHODS USED
HPLCMSAAA
↓ VIEW REPORT · 5IO2NX7
RESEARCH APPLICATIONS

What the literature covers.

  • ●Dual GHRH-R and GHSR-1a pathway research in a single preparation
  • ●Complementary GH secretagogue mechanism studies
  • ●Combined pulsatile and tonic GH release pathway investigations
  • ●Widely referenced combination in preclinical GH axis research literature

All compounds sold by Lumo are intended strictly for in vitro research and laboratory use only. These products are NOT intended for human consumption, medical, veterinary, or household use. By purchasing from Lumo, you acknowledge that you are a qualified researcher or institution and will use these products solely for research purposes in compliance with all applicable laws and regulations.

L-003

Stay current.

New lot releases, research updates, and product announcements.

Unsubscribe anytime. Research use communications only.

Research Use Only · Not for Human Consumption · For Laboratory Research Purposes Only

Your Cart

● All items for research use only. Not for human consumption.
●

Your cart is empty

Add compounds to get started

Lumo · Research Peptides